CENTESSA PHARMACEUTICALS-ADR (CNTA) Stock News

NASDAQ:CNTA - Nasdaq - US1523091007 - ADR - Currency: USD

16.06 +0.37 (+2.36%)

After market: 16.06 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CNTA Latest News, Press Relases and Analysis

All

Press Releases

8 hours ago - By: Investor's Business Daily - Mentions: RY RY.CA ALKS TAK ...

Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.

a month ago - By: Yahoo Finance - Mentions: AGEN HON ITGR TTEK ...

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock

a month ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year

a month ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year

2 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

2 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

2 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

2 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

2 months ago - By: Benzinga - Mentions: IFRX

This Centessa Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday

3 months ago - By: Yahoo Finance - Mentions: GEHC IDYA BCYC EWTX ...

Here's Why GE HealthCare Stock Sank in April

3 months ago - By: Yahoo Finance - Mentions: XYLD JEPQ MTB

High-yield savings rates today: May 5, 2025 | APYs remain elevated despite a slight decline

3 months ago - By: Yahoo Finance - Mentions: DHI CMG

Is Centessa Pharmaceuticals plc (CNTA) the Best Small Cap Stock to Buy with the Biggest Upside Potential?

4 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024

4 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024

5 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting

5 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting

5 months ago - By: Benzinga - Mentions: AVAV TBBK TEO BOX ...

AeroVironment Posts Downbeat Results, Joins Box, CrowdStrike And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

6 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

6 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer

6 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer

8 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update

8 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update

9 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

9 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

10 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Presents Preclinical Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)

10 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Presents Preclinical Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)

10 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares

10 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares

10 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares

10 months ago - By: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares